Jpmorgan Chase & CO Compass Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,185,480 shares of CMPX stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,185,480

Previous 272,328 702.52%

Holding current value

$10.2 Million

Previous $394,000 953.81%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$1.4 - $3.9 $2.68 Million - $7.46 Million	1,913,152 Added 702.52%	2,185,480 $4.15 Million
Q4 2024 Feb 12, 2025	BUY	$1.35 - $1.98 $307,616 - $451,170	227,864 Added 512.47%	272,328 $394,000
Q3 2024 Dec 26, 2024	SELL	$0.8 - $1.88 $1,135 - $2,667	-1,419 Reduced 3.09%	44,464 $81,000
Q3 2024 Nov 08, 2024	SELL	$0.8 - $1.88 $1,135 - $2,667	-1,419 Reduced 3.09%	44,464 $81,000
Q2 2024 Dec 26, 2024	BUY	$1.0 - $1.85 $1,419 - $2,625	1,419 Added 3.19%	45,883 $45,000
Q2 2024 Aug 12, 2024	BUY	$1.0 - $1.85 $7,530 - $13,930	7,530 Added 19.63%	45,883 $45,000
Q1 2024 Dec 26, 2024	SELL	$1.2 - $2.29 $7,333 - $13,994	-6,111 Reduced 13.74%	38,353 $75,000
Q1 2024 May 10, 2024	SELL	$1.2 - $2.29 $28,774 - $54,911	-23,979 Reduced 38.47%	38,353 $75,000
Q4 2023 Dec 26, 2024	BUY	$1.4 - $1.98 $25,015 - $35,378	17,868 Added 40.19%	62,332 $97,000
Q4 2023 Feb 12, 2024	SELL	$1.4 - $1.98 $569 - $805	-407 Reduced 0.65%	62,332 $97,000
Q3 2023 Nov 14, 2023	SELL	$1.87 - $3.25 $15,754 - $27,381	-8,425 Reduced 11.84%	62,739 $123,000
Q2 2023 Aug 11, 2023	BUY	$2.64 - $3.48 $186,798 - $246,234	70,757 Added 17385.01%	71,164 $226,000
Q1 2023 May 11, 2023	BUY	$3.14 - $5.48 $1,277 - $2,230	407 New	407 $1,000
Q1 2022 May 11, 2022	SELL	$1.25 - $3.5 $29,686 - $83,121	-23,749 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.88 - $3.98 $68,397 - $94,521	23,749 New	23,749 $75,000

Others Institutions Holding CMPX

# of Institutions

105

Shares Held

101M

Call Options Held

18.2K

Put Options Held

2.51M

View Full List

About Compass Therapeutics, Inc.

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $474M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

More about CMPX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Compass Therapeutics, Inc. Transaction History